Exchange transfusion has just a few elective indications: the therapy of haemolytic disease of the newborn (HDN) and cases in which red cell exchange is appropriate but the child is too small to use a cell separator.
Exchange transfusion has several positive effects in the therapy of HDN: it removes the neonatal red cells, which are destined to be destroyed and hence to generate bilirubin, the already produced bilirubin, and the offending antibody1. Moreover, exchange transfusion also corrects anaemia, if present1.
Physiological bases of exchange transfusion in HDN
The offending antibody is an IgG and has a substantial extravascular distribution (about 60%). As the equilibration between the intravascular and extravascular compartments is slow (≈1–3%/hour)2, removal of the antibody through the exchange may only be partial and the residual or newly produced neonatal red cells are still exposed to the risk of haemolysis. It is, therefore, justified to remove as many neonatal red cells as possible and to maintain an elevated total haemoglobin concentration with compatible adult red cells, so as to inhibit the autologous production from the bone marrow. The bilirubin in the intravascular space is only a small part of the total and, although equilibration is fast, exchange transfusion is not particularly successful: rebound is immediate1, so that at the end of an exchange during which 87% of neonatal red cells are removed, the concentration of bilirubin is still 60% of that at the start of the exchange3. It is, therefore, advisable to prevent the production of bilirubin by removing the “doomed” red cells in time1.
The removal of red cells
Alexander S. Wiener (1907–1976), co-worker of Karl Landsteiner in the discovery of the Rh factor (1940) and pioneer of the therapy of HDN, asserted4 that he and Wexler had been the first to derive the formula which describes the removal of red cells during exchange transfusion5
where v is the total exchanged volume, V is the patient’s blood volume and e is the transcendental number, base of the natural logarithm. However, he later stated that his formula was not correct because it did not take into consideration the difference between the patient’s haematocrit and that of the transfused blood6. Moreover, according to others, even when the two haematocrits happen to be the same, the formula should be modified to account for the difference between venous haematocrit and body haematocrit7. Wiener also stated that it was obvious that, for an equal exchanged volume, exchange transfusion would be more efficient, the more the neonate was anaemic6. Taken together, these opinions risk misleading the reader seriously.
Wiener’s formula describes a continuous flow exchange. However, during exchange transfusion, neonatal blood is replaced by donor blood, withdrawing and transfusing alternatively 5–20 mL of blood. The exchange is, therefore, intermittent. It can be demonstrated (see Appendix A) that when blood is first withdrawn and then transfused, at each cycle:
where s is the volume exchanged at each cycle (cycle volume), V is the patient’s blood volume, k is the ratio between body and venous haematocrit (= 0.91)7 and n is the number of exchange cycles.
Analogously, when blood is first transfused and then withdrawn:
In Appendix B, the reader will find instructions for programming a spreadsheet to calculate the residual fraction according to the cycle volume and the neonate’s blood volume. Some exemplary data are shown in table I.
Table I.
Residual fraction (%) of the neonatal red cells | ||||
---|---|---|---|---|
Intermittent flow | Continuous flow | |||
Cycle | Total exchanged volume (% of the blood volume) | Withdrawal first | Transfusion first | |
1 | 1 0 | 89.0 | 90.0 | 89.5 |
2 | 2 0 | 79.2 | 81.0 | 80.1 |
5 | 5 0 | 55.9 | 59.1 | 57.4 |
1 0 | 100 | 31.2 | 34.9 | 32.9 |
2 0 | 200 | 9.8 | 12.2 | 10.8 |
As can be easily noted, the efficiency of the exchange is greater when blood is first withdrawn. The difference is proportional to the volume exchanged at each cycle. The cycle volume influences the efficiency of the exchange in a peculiar way: when blood is first withdrawn, efficiency is proportional to the cycle volume, whereas when blood is first transfused, efficiency is inversely proportional to the cycle volume. However, as the cycle volume rarely exceeds 10% of the total blood volume, the differences are limited to a few percentage points.
Formulae (1) and (2) do not include references to the patient’s haematocrit, nor to the haematocrit of the transfused blood: contrary to the above cited opinions, the residual fraction only depends on the terms represented in the two formulae.
Absolute amount of neonatal red cells
However, we should be more interested in the absolute amount of the residual neonatal red cells, rather than the fraction. In this case it is clear that, if the neonate is anaemic, during the exchange it is possible to fall under a minimum target level of neonatal red cells earlier.
Incidentally, this was the probable meaning of Wiener’s sentence cited above.
Figure 1 compares the cases of two hypothetical neonates, with the same weight (blood volume) but initial haematocrits of 25% and 50%. If our aim is to leave no more than 9 mL of neonatal red cells (about 10% of the normal initial volume), the target is met in the first case after 14 cycles of exchange and in the second after 20 cycles.
The neonate’s venous haematocrit at the end of the procedure
During the exchange transfusion, neonatal red cells are progressively substituted by the transfused cells. The venous haematocrit after n cycles of exchange (Hn) principally depends on the haematocrit of the transfused blood (HD) and, moreover, the volume exchanged at each cycle (s), the number of cycles (n), and the neonate’s initial venous haematocrit (HV), according to the following formula (see Appendix A):
The above formula is appropriate when the exchange begins withdrawal of blood. The analogous formula for the opposite case is given in Appendix A.
Figure 2 shows the kinetics of the substitution of the transfused blood for the neonatal red cells and the changes of the patient’s venous haematocrit during the exchange transfusion.
Choosing the haematocrit of the blood to be transfused
It has been noted that the haematocrit of the transfused blood does not influence the efficiency of the procedure and, therefore, it may be chosen on the basis of other considerations: the haematocrit should not be too low, in order not to induce a state of anaemia and to correct it, if present; an elevated haematocrit at the end of the procedure exerts an inhibitory effect on autologous marrow production, which is in any case destined to precocious destruction. On the other hand, an excessive haematocrit of the transfused blood limits the total exchanged volume, lest the neonate be made too polycythaemic6. This entails the risk of an insufficient exchange6. Since the 1950s, it has been customary to concentrate the reconstituted whole blood up to a haematocrit of about 50%6. This practice was confirmed by the recent Italian guidelines8. Probably, this choice stems from the fact that the normal neonatal haematocrit is about 50%. Such an elevated haematocrit is due to the greater affinity for oxygen by the foetal haemoglobin that, therefore, has a lower oxygen carrying capacity to the tissues. In fact, haematocrit rapidly decreases in the weeks following birth. After about 2 months, even though the substitution by adult haemoglobin is not complete, the haematocrit has fallen to about 35%9. Therefore, a haematocrit of 50% is not necessary and it could be decreased to 45% or less, so as to profit from the greater volume of reconstituted whole blood available to increase the removal of neonatal red cells or bilirubin.
Exchange transfusion in the therapy of sickle cell anaemia
Exchange transfusion is used preferentially or as an alternative to simple transfusion in a number of indications in children with sickle cell anaemia10. In adults or bigger children, automated red cell exchange is the preferred procedure (this topic will be dealt with in the next article of this series), but the manual exchange of whole blood may be necessary for smaller children, given the limitations in the extracorporeal volume. In this case, the removal kinetics is the same as that described above. The difference lies in the target, which is not to remove as many autologous red cells as possible, but to reduce the percentage of haemoglobin S without increasing the haematocrit excessively, in order not to cause a high blood viscosity11.
The relevant parameters are, therefore, the percentage of haemoglobin S and the venous haematocrit. This latter can be calculated from (3). The first part of equation (3) represents the contribution (Hp) of the residual autologous red cells (see Appendix A):
Therefore, the percentage of haemoglobin S after n cycles (HbSn) will be:
where HbS0 is the initial percentage of haemoglobin S.
Limitations of the formulae
Most of the terms contained in the formulae can be measured with precision. However, blood volume is, usually, only estimated with the aid of a formula12 and the value of the correction for the body haematocrit is taken from the literature7. In this regard, however, it should be noted that the value may differ from the normal significantly, in case of splenomegaly13.
Moreover, the formulae assume that:
- there is no dead space in the transfusion set used for the exchange;
- the transfused blood mixes immediately in the circulation;
- the blood volume does not change during the procedure;
- all transfused red cells survive in the circulation (at least till the end of the exchange);
- the patient’s red cells are not destroyed during the procedure.
As regards the first assumption, after the transfusion step, before blood is again withdrawn, it is advisable to aspirate a small volume of blood from the patient and to reinfuse it. The second and third assumptions are plausible. The fourth is also plausible, in the case of HDN, because the neonate’s reticuloendothelial system should preferentially remove the sensitised autologous red cells. Finally, the fifth assumption depends on the duration of the procedure.
Conclusions
The exchange is more efficient if blood is first withdrawn and if the volume exchanged at each cycle is large. However, when the cycle volume does not exceed 10% of the patient’s blood volume, the difference remains within a few percentage points.
The removed fraction of the patient’s red cells only depends on the cycle volume and the number of cycles. However, the absolute amount of residual red cells also depends on the patient’s initial venous haematocrit. The haematocrit of the transfused blood influences the final haematocrit of the patient, but not the removal efficiency.
Appendix A – Derivation of the formulae
The fraction of neonatal red cells removed in the exchange transfusion
If we denote the volume exchanged at each cycle with s and the blood volume of the patient with V, then the fraction removed at each cycle, when blood is first withdrawn, should be .
However, the red cells are more concentrated in the venous blood than in the whole vascular system, so that:
where HB is the body haematocrit, HV the venous haematocrit and k is the correction factor (= 0.91)7.
Let RB be the total volume of the patient’s red cells:
(1) |
Let RS be the volume of the patient’s red cells in the volume exchanged at each cycle:
Then the removed fraction will be equal to , or:
and the residual fraction will be:
At the next cycle, the volumes exchanged will be the same, but the removal will concern the residual amount only , therefore the residual fraction after the second cycle will be:
It is easy to see that after n cycles:
(2) |
When blood is first transfused, on the basis of very similar considerations to those above, it can be derived that:
(3) |
In the above formulae, only the correction for the difference between venous and body haematocrit was used. However, a further correction is advisable when the haematocrit is measured by centrifugation because of the small amount of plasma (≈ 2%) that remains entrapped in the red cell column8. In this case k = 0.91 x 0.98 = 0.89.
Absolute amount of neonatal red cells remaining after the exchange transfusion
The volume of the neonatal red cells remaining after the exchange cycles (RR) can be derived from formula (2):
or formula (3), as appropriate:
RB can be derived from (1). The removed volume can be easily calculated by difference.
Venous haematocrit after the exchange transfusion
Let us consider the case in which blood is first withdrawn. Let and b = 1 − a.
At each cycle, a fraction equal to a of the donor’s red cells present in the circulation will be removed, whilst a volume DS will be added.
Table II shows the situation in the first cycles of an exchange transfusion.
Table II.
Withdrawal step | Transfusion step | ||
---|---|---|---|
CYCLE | Removed VGR | Remaining VGR | Final VGR |
1 | 0 | 0 | DS |
2 | a × DS | b × DS | DS + b × DS |
3 | a × (1 + b) × DS | (b + b2) × DS | (1 + b + b2 ) × DS |
4 | a × (1 + b + b2) × DS | (b + b2 + b3) × DS | (1 + b + b2 + b3) × DS |
… | … | … | … |
n | a × (1 + b + b2 +…+ bn−2 ) × DS | (b + b2 +…+ bn−1 ) × DS | (1 + b + b2 +…+ bn−1 ) × DS |
As can be seen from the far right column, at each cycle, a term to the power n − 1 is added in parentheses.
By definition, we know that:
where HD is the haematocrit of the transfused blood, and that:
where Hd is the venous haematocrit (in the patient’s circulation) of the transfused red cells after cycle n.
Therefore:
By substitution, the following formula is obtained:
In the same way, we can derive the venous haematocrit of the patient’s red cells after the exchange transfusion (Hp):
Therefore, at the end of n cycles of exchange transfusion, the total venous haematocrit will be the sum of the two partial ones7:
This formula allows the calculation of the venous haematocrit of the patient during the exchange transfusion (Hn), starting from the patient’s venous haematocrit before the procedure (HV) and the haematocrit of the transfused blood (HD).
Analogously, when blood is first transfused, the following formula can be derived:
Appendix B – Programming a spreadsheet*
Spreadsheets are programmes used to perform calculations, especially on large data series.
The most renowned is Excel, which is part of the MS Office (Microsoft) package.
However, the following instructions are equally valid for other similar programmes, such as OpenOffice.org Calc and Gnumeric. As these are less well known, here is a brief description.
OpenOffice.org Calc
This is part of the OpenOffice.org suite. It is freely downloadable from http://www.openoffice.org/ and is available for Windows (98 and later), Mac Os X, Linux and other operating systems. Calc can open, modify, and save files in Excel and other formats, besides its own native one. The available functions are similar to those of Excel.
Gnumeric
Gnumeric is part of the GNU project. It can be freely downloaded from http://www.gnome.org/projects/gnumeric/ and is available in versions for Windows (XP, 2000 or later) and Linux. Gnumeric is able to open, modify and save files in Excel and other formats. Available functions are similar to those of Excel but, in addition, Gnumeric offers a series of statistical tests.
The following instructions only presuppose a basic knowledge of how to use a personal computer.
Instructions
Open the spreadsheet. The programme automatically proposes a new sheet (table), with rows progressively numbered starting from 1 and columns alphabetically labelled starting from A.
Each cell is identified by a couple of column and row identifiers: e.g., the top leftmost cell is A1; the fourth from top in the B column is B4 and so on. Each cell may contain numerical values, formulae or explanatory text. This last is useful for reminding the user of the meaning of the adjacent values or formulae.
Calculation of the residual fraction and absolute quantity of the patient’s red cells
Enter the text listed in Table III into the appropriate cells. Enter the values listed in Table IV.
Table III.
Cell | Text to be entered |
---|---|
A1 | Kinetics of exchange tansfusion |
A3 | Patient’s blood volume (mL) |
A4 | Volume of each exchange cycle (mL) |
A5 | Patient’s initial venous haematocrit (%) |
A6 | Haematocrit of the blood to be transfused (%) |
A7 | Correction factor for the body haematocrit |
A9 | Cycle |
B9 | Exchanged volume (% of the blood volume) |
C9 | Residual fraction (%) |
D9 | Residual quantity (mL) |
Table IV.
Cell | Value to be entered |
---|---|
B3 | Blood volume of the patient (mL), e.g. 200 |
B4 | Volume of each exchange cycle (mL), e.g. 20 |
B5 | Initial haematocrit of the patient, e.g. 25 |
B6 | Haematocrit of the transfused blood, e.g. 50 |
B7 | Correction factor for body haematocrit: 0.91 |
If the cell seems to be covered by the text of the cell at its left, resize the adjacent cell or begin to write in the desired cell: this will prevent the text in the left cell from exceeding the border.
Enter the numbers from 0 to 25 into the cells from A10 toA35.
These numbers represent the cycles of the exchange transfusion. The number of cycles can be increased further at will. Enter the formulae listed in Table V.
Table V.
Cell | Formula to be entered |
---|---|
B10 | =$B$4/$B$3*A10*100 |
C10 | =100* POWER(1−$B$4/$B$3/$B$7,A10) |
D10 | =$B$5/100*$B$7*$B$3*C10/100 |
Right click on cell B10; choose “Copy” from the pop-up menu; paste the cell (“Paste”) on cells B11 to B35 (or further on, if numbering continues past A35).
In the same way, copy the formula in C10 on cells C11 to C35 and that in D10 on cells D11 to D35. The spreadsheet transposes the references to the cells contained in the formulae in an appropriate way. Calculated values appear immediately. Row 10 contains the starting values, before the exchange. Cells B10–B35, C10–C35 and D10–D35 contain the total exchanged volume, expressed as a percentage of the blood volume, the residual fraction (%) and the residual absolute amount (mL) of the patient’s red cells, respectively. If the user changes one or more values in cells B3–B7, the results in the cells B10–B35, C10–C35 and D10–D35 are immediately recalculated by the programme.
When blood is first transfused, the formula to be entered into cell B10 is:
The other instructions are the same.
Calculation of the patient’s venous haematocrit after the exchange transfusion
(The following instructions presuppose that the previous ones have been correctly performed).
Enter text and formulae contained in Table VI.
Table VI.
Cell | Text to be entered |
---|---|
E9 | Patient’s venous haematocrit |
Formula to be entered | |
E10 | =$B$5* POWER(1−$B$4/$B$3/$B$7,A10) + $B$6*(1− POWER(1−$B$4/$B$3/$B$7,A10)) |
Copy cell E10 into cells E11–E35 (or further on, if numbering continues past A35). Cells E10–E35 will show the venous haematocrit of the patient after each exchange cycle.
If blood is first transfused, the formula to be entered into E10 is:
Calculation of the percentage of haemoglobin S
(The following instructions presuppose that the previous ones have been correctly performed).
Enter the text, the value, and the formula contained in Table VII.
Table VII.
Cell | Text to be entered |
---|---|
A8 | Initial percentage of HbS |
F9 | Residual percentage of HbS |
Value to be entered | |
B8 | Initial percentage of HbS, e.g. 70 |
Formula to be entered | |
F10 | =$B$5* POWER(1−$B$4/$B$3/$B$7,A10)/E10*$B$8 |
Copy cell F10 into cells F11–F35 (or further on, if numbering continues past A35). Cells F10–F35 will show the percentage of haemoglobin S after each exchange cycle.
If blood is first transfused, the formula to be entered into F10 is:
Footnotes
Italian readers using the localized (Italian) versions of the spreadsheets should follow the instructions in the Italian translation of this paper, which is available on line at http://www.transfusionmedicine.org/. Briefly, “potenza” should be substituted for “power” and “;” should be substituted for “,”.
References
- 1.Nathan DG, Oski FA. Hematology of Infancy and Childhood. 3. Philadelphia, PA: WB Saunders; 1987. [Google Scholar]
- 2.Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange. Malden, MA: Blackwell Science; 1999. [Google Scholar]
- 3.Greenough A. Rhesus disease: postnatal management and outcome. Eur J Pediatr. 1999;158:689–93. doi: 10.1007/s004310051180. [DOI] [PubMed] [Google Scholar]
- 4.Wiener AS. Blood group museum. II. Some mathematical curiosities and amusements. Am J Clin Pathol. 1964;3:307–8. doi: 10.1093/ajcp/41.3.307. [DOI] [PubMed] [Google Scholar]
- 5.Wiener AS, Wexler IB. The use of heparin when performing exchange blood transfusions in newborn infants. J Lab Clin Med. 1946;31:1016–9. [PubMed] [Google Scholar]
- 6.Wiener AS, Wexler IB, Brancato GJ. Treatment of erythroblastosis fetalis by exchange transfusion. Statistical analysis of results. J Pediatr. 1954;5:546–68. doi: 10.1016/s0022-3476(54)80117-x. [DOI] [PubMed] [Google Scholar]
- 7.Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 10. Oxford, Great Britain: Blackwell Science; 1997. [Google Scholar]
- 8.SIMTI and SIN Task Force. Recommendations on transfusion therapy in neonatology. Blood Transfus. 2006;4:158–80. [Google Scholar]
- 9.Greer JP, Foerster J, Lukens JN, et al., editors. Wintrobe’s Clinical Hematology. 11. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003. [Google Scholar]
- 10.Amrolia PJ, Almeida A, Halsey C, et al. Therapeutic challenges in childhood sickle cell disease. Part 1: Current and future treatment options. Br J Haematol. 2003;120:725–36. doi: 10.1046/j.1365-2141.2003.04143.x. [DOI] [PubMed] [Google Scholar]
- 11.Davies SC, Roberts-Harewood M. Blood transfusion in sickle cell disease. Blood Reviews. 1997;11:57–71. doi: 10.1016/s0268-960x(97)90012-6. [DOI] [PubMed] [Google Scholar]
- 12.Lentner C, editor. Geigy Scientific Tables. 8. Vol. 2. Basle, Switzerland: Ciba-Geigy; 1987. [Google Scholar]
- 13.Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 8. Oxford, Great Britain: Blackwell Scientific Publications; 1987. [Google Scholar]